Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0109 Transporter Info
Gene Name	SLC16A5
Transporter Name	Monocarboxylate transporter 6
Gene ID	9121
UniProt ID	O15375

Post-Translational Modification of This DT
Overview of SLC16A5 Modification Sites with Functional and Structural Information
Sequence	M P Q A L E R A D G S W A W V V L L A T M V T Q G L T L G F P T C I G I F F T E L Q W E F Q A S N S E T S W F P S I L T A V L H M A G P L C S I L V G R F G C R V T V M L G G V L A S L G M V A S S F S H N L S Q L Y F T A G F I T G L G M C F S F Q S S I T V L G F Y F V R R R V L A N A L A S M G V S L G I T L W P L L S R Y L L E N L G W R G T F L V F G G I F L H C C I C G A I I R P V A T S V A P E T K E C P P P P P E T P A L G C L A A C G R T I Q R H L A F D I L R H N T G Y C V Y I L G V M W S V L G F P L P Q V F L V P Y A M W H S V D E Q Q A A L L I S I I G F S N I F L R P L A G L M A G R P A F A S H R K Y L F S L A L L L N G L T N L V C A A S G D F W V L V G Y C L A Y S V S M S G I G A L I F Q V L M D I V P M D Q F P R A L G L F T V L D G L A F L I S P P L A G L L L D A T N N F S Y V F Y M S S F F L I S A A L F M G G S F Y A L Q K K E Q G K Q A V A A D A L E R D L F L E A K D G P G K Q R S P E I M C Q S S R Q P R P A G V N K H L W G C P A S S R T S H E W L L W P K A V L Q A K Q T A L G W N S P T
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	195
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A5 Serine 195 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A5			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	451
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A5 Serine 451 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	194
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A5 Threonine 194 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A5			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	200
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A5 Threonine 200 has the potential to affect its expression or activity.
Ubiquitination
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	418
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Alanine 418 has the potential to affect its expression or activity.
Glutamicacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	423
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Glutamicacid 423 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	483
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Glutamicacid 483 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	461
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Glutamine 461 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Glycine 466 has the potential to affect its expression or activity.
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 421 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 422 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A5			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 426 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A5			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	443
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 443 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	448
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 448 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC16A5			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Lysine 489 has the potential to affect its expression or activity.
Proline	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	462
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Proline 462 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	488
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Proline 488 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	401
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Serine 401 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	396
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Tyrosine 396 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A5			[4]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	397
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A5 Valine 397 has the potential to affect its expression or activity.

References
1	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
2	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
3	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
4	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
5	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
6	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
7	Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. Proteomics. 2018 Aug;18(15):e1700388.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence